San
Francisco, 04 October 2018, The global women’s health therapeutics market size
is expected to reach USD 210.9 billion by 2025, according to a new report by
Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.8% over
the forecast period. Entry of effective drugs, a rise in awareness about early
diagnosis and treatment, along with prevalence of chronic diseases are among
the key factors likely to drive the market during the forecast period.
The women’s health therapeutics market is
expected to witness high growth in the forthcoming years due to increasing
investment by key market players to fulfill demand in areas of infection,
cancer, and pregnancy-related complications. In October 2016, Prelude
Fertility, Inc. received USD 200 million from the Reproductive Biology
Associates (RBA) and My Egg Bank North America (MEB) that focuses on providing
fertility services and treatment to people with delayed childbirth. Juneau
Biosciences, LLC has deployed USD 35 million until 2017 towards development of
molecular diagnostics and therapeutics for endometriosis (uterus) conditions.
In January 2018, Melinta Therapeutics, Inc.
acquired The Medicines Company’s infectious diseases business. This acquisition
would help to the former expand its portfolio by offering life-saving treatment
options. In November 2017, Biocon launched KRABEVA, a biosimilar used for the
treatment of metastatic colorectal, cervical, ovarian, and brain cancer.
Increasing investments by top market players are anticipated to propel the
global market over the forecast period.
There is significant unmet need associated
with treatment options for female sexual dysfunction. Currently, there are no
Food and Drug Administration (FDA)-approved drugs for the treatment of female
sexual dysfunction and many promising molecules are in late stage of
development phase. Some of these molecules include LibiGel by BioSante
Pharmaceuticals and Femprox by Apricus Bio, currently in Phase III and Phase II
of clinical trials respectively in U.S.
Full Research Report On Women’s Health Therapeutics Market Analysis:
www.grandviewresearch.com/industry-analysis/womens-health-therapeutics-market
www.grandviewresearch.com/industry-analysis/womens-health-therapeutics-market
Further key findings from the report suggest:
·
By type, infection accounted for the
largest market share in 2017 and is expected to maintain its dominance during
the forecast period due to rising drug approvals, availability of diagnostic
tests and treatments, and high incidence of infectious diseases
·
Ovarian cancer is anticipated to be the
fastest-growing sub-segment of oncology during the forecast period due to high
prevalence of ovarian cancer and approval of new and improved drugs
·
North America is expected to maintain its
dominance in the coming years due to high awareness about women’s health,
increase in number of advanced diagnostic and treatment methods, mergers and
acquisitions by market players, and rise in infections and cancer cases
·
Asia Pacific is likely to witness
significant growth over the next decade due to improving healthcare facilities,
increase in commercialization and approval of products, and investment by
market players
·
Some of the key players in women’s health therapeutics
market are Bayer AG, Merck & Co., Pfizer, Teva Pharmaceutical Industries
Ltd, AstraZeneca, Bristol-Myers Squibb (BMS) Company, Eli Lilly and Company,
Novartis AG, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Mylan N.V., Sun
Pharmaceutical Industries Ltd, and Sanofi.
Browse
More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global women’s health therapeutics
market based on type and region:
Women’s Health Therapeutics Type Outlook
(Revenue, USD Million, 2014 - 2025)
·
Infection
·
Pregnancy
·
Oncology
o
Cervical Cancer
o
Ovarian Cancer
o
Uterine Cancer
o
Vaginal & Vulvar Cancer
Women’s Health Therapeutics Regional
Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
o
France
o
Spain
o
Italy
·
Asia Pacific
o
China
o
Japan
o
India
·
Latin America
o
Brazil
o
Mexico
·
Middle East & Africa
o
South Africa
Access
Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-womens-health-therapeutics-market
www.grandviewresearch.com/press-release/global-womens-health-therapeutics-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For
more information: www.grandviewresearch.com
No comments:
Post a Comment